Efficacy of novel β(3)‐adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post‐hoc analysis of a randomized, double‐blind, placebo‐controlled phase 3 study

OBJECTIVES: To investigate the efficacy of vibegron on nocturia in patients with overactive bladder. METHODS: Among the Japanese overactive bladder patients enrolled in the placebo‐controlled, multicenter, randomized, double‐blind phase 3 study of vibegron, a total of 669 patients with nocturia (≥1...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Masaki, Takeda, Masayuki, Gotoh, Momokazu, Yokoyama, Osamu, Kakizaki, Hidehiro, Takahashi, Satoru, Masumori, Naoya, Nagai, Shinji, Hashimoto, Keita, Minemura, Kazuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles: Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912249/
https://www.ncbi.nlm.nih.gov/pubmed/30557916
http://dx.doi.org/10.1111/iju.13877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912249/
https://www.ncbi.nlm.nih.gov/pubmed/30557916
http://dx.doi.org/10.1111/iju.13877

Ejemplares similares